INTRODUCTION: Increased alcohol and cannabis consumption and related harms have been reported since the beginning of the COVID-19 pandemic. Existing evidence shows that substance use and related harms differ by gender. Yet, no Canadian study has applied a gendered lens to alcohol and cannabis consumption use during this time. Our objectives were to (1) provide gender-specific prevalence estimates of self-reported increased alcohol and cannabis use; and (2) examine gender-specific associations between sociodemographic and mental health variables and alcohol and cannabis use. METHODS: Using data from the Survey on COVID-19 and Mental Health, we calculated nationally representative, gender-specific prevalence estimates and disaggregated them by sociodemographic and mental health variables. Four logistic regression models were used to assess the likelihood of self-reported increased alcohol and cannabis use. RESULTS: The prevalence of self-reported increase in alcohol use (16.2% women; 15.2% men) and cannabis use (4.9% women; 5.8% men) did not differ by gender. For both genders, income, racialized group membership, working in the past week, being a parent/legal guardian of a child aged under 18 and screening positive for depression and anxiety were associated with increased alcohol use. Men and women who were between the ages of 18 to 44, screened positive for depression, or both, were more likely to report increased cannabis use. For women, education was significantly associated with increased alcohol use. For men, being a parent/legal guardian was significantly associated with lower odds of increased cannabis use. CONCLUSION: Sociodemographic factors, as well as depression and anxiety, were similarly associated with increased alcohol and cannabis use for both men and women in the second wave of the pandemic.
INTRODUCTION: Increased alcohol and cannabis consumption and related harms have been reported since the beginning of the COVID-19 pandemic. Existing evidence shows that substance use and related harms differ by gender. Yet, no Canadian study has applied a gendered lens to alcohol and cannabis consumption use during this time. Our objectives were to (1) provide gender-specific prevalence estimates of self-reported increased alcohol and cannabis use; and (2) examine gender-specific associations between sociodemographic and mental health variables and alcohol and cannabis use. METHODS: Using data from the Survey on COVID-19 and Mental Health, we calculated nationally representative, gender-specific prevalence estimates and disaggregated them by sociodemographic and mental health variables. Four logistic regression models were used to assess the likelihood of self-reported increased alcohol and cannabis use. RESULTS: The prevalence of self-reported increase in alcohol use (16.2% women; 15.2% men) and cannabis use (4.9% women; 5.8% men) did not differ by gender. For both genders, income, racialized group membership, working in the past week, being a parent/legal guardian of a child aged under 18 and screening positive for depression and anxiety were associated with increased alcohol use. Men and women who were between the ages of 18 to 44, screened positive for depression, or both, were more likely to report increased cannabis use. For women, education was significantly associated with increased alcohol use. For men, being a parent/legal guardian was significantly associated with lower odds of increased cannabis use. CONCLUSION: Sociodemographic factors, as well as depression and anxiety, were similarly associated with increased alcohol and cannabis use for both men and women in the second wave of the pandemic.
Authors: Alexander Posis; John Bellettiere; Sandy Liles; John Alcaraz; Benjamin Nguyen; Vincent Berardi; Neil E Klepeis; Suzanne C Hughes; Tianying Wu; Melbourne F Hovell Journal: Prev Med Rep Date: 2019-03-16
Authors: MacKenzie R Peltier; Terril L Verplaetse; Yann S Mineur; Ismene L Petrakis; Kelly P Cosgrove; Marina R Picciotto; Sherry A McKee Journal: Neurobiol Stress Date: 2019-02-08
Authors: Lindsey A Hines; Tom P Freeman; Suzanne H Gage; Stanley Zammit; Matthew Hickman; Mary Cannon; Marcus Munafo; John MacLeod; Jon Heron Journal: JAMA Psychiatry Date: 2020-10-01 Impact factor: 21.596
Authors: Thalia MacMillan; Matthew J Corrigan; Kevin Coffey; Christine D Tronnier; Donna Wang; Kathryn Krase Journal: Int J Ment Health Addict Date: 2021-01-26 Impact factor: 3.836
Authors: Anne C Gadermann; Kimberly C Thomson; Chris G Richardson; Monique Gagné; Corey McAuliffe; Saima Hirani; Emily Jenkins Journal: BMJ Open Date: 2021-01-12 Impact factor: 2.692
Authors: Mark É Czeisler; Rashon I Lane; Emiko Petrosky; Joshua F Wiley; Aleta Christensen; Rashid Njai; Matthew D Weaver; Rebecca Robbins; Elise R Facer-Childs; Laura K Barger; Charles A Czeisler; Mark E Howard; Shantha M W Rajaratnam Journal: MMWR Morb Mortal Wkly Rep Date: 2020-08-14 Impact factor: 17.586